
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical solution containing povidone-iodine, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing povidone-iodine are listed in solution form, for eye (ophthalmic) use only.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Povidone-iodine is a broad-spectrum iodophor antiseptic that compounding pharmacies prepare as sterile ophthalmic drops, nasal sprays, otic solutions and topical preparations by prescription.
Povidone-iodine (PVP-I) is iodine bound to the water-soluble polymer polyvinylpyrrolidone. The polymer holds the iodine in a stable, less irritating form and slowly releases free iodine, which is the part that kills microbes. Free iodine disrupts membranes, proteins, respiration and nucleic acids at once, so it is active against bacteria, viruses, yeasts, molds and protozoa, and no bacterial resistance to iodine is known. Manufactured products include Betadine Solution 10% and related scrubs, sprays and swabs, sold over the counter under the OTC monograph as first aid antiseptics for minor cuts, scrapes and burns, and Betadine 5% Sterile Ophthalmic Prep Solution (Alcon), FDA-approved for prepping the periocular region and irrigating the ocular surface before surgery. A prescriber might order compounded povidone-iodine in a dilute ophthalmic, nasal or otic strength not manufactured, or in a sterile vehicle for a specific site. Compounded preparations are not FDA-approved and require a prescription.
Povidone-iodine products carry no boxed warning. They are for external use only; the ophthalmic prep label warns it is not for injection into or irrigation inside the eye. Do not use it if you are allergic to iodine or any ingredient, over large areas of the body, or on deep or puncture wounds, serious burns or animal bites without asking your prescriber. Stop and call your prescriber if irritation, blistering or signs of infection develop or if you need it for more than a week. Some iodine is absorbed through skin and mucous membranes, so the ophthalmic label advises caution with thyroid disorders and use in pregnancy only if clearly needed. Drugs.com's breastfeeding monograph, citing primary studies, reports that maternal use near delivery raises milk iodine and has caused temporary underactive thyroid in breastfed infants, so use the lowest concentration on the smallest area for the shortest time while nursing, and ask your prescriber before repeated use. If side effects bother you, talk to your prescriber or pharmacist.
PVP-I is an iodophor in which triiodide is complexed to polyvinylpyrrolidone; in aqueous solution it establishes an equilibrium of iodine species, and free molecular iodine is the microbicidal fraction. Activity is nonspecific oxidation of membranes, electron transport, protein synthesis and nucleic acids, giving a spectrum that includes Staphylococcus, Pseudomonas, mycobacteria, Candida, dermatophytes and enveloped and nonenveloped viruses. Labeled indications: Betadine 5% Sterile Ophthalmic Prep Solution (NDA 018634) for periocular prepping and ocular surface irrigation; Betadine Solution 10% and similar OTC monograph products as first aid antiseptics. Prescribers have ordered compounded dilute povidone-iodine as ophthalmic drops for adenoviral and neonatal conjunctivitis, otic solutions for otitis externa and otomycosis, nasal and sinus irrigations, and wound irrigations (Capriotti and Capriotti, Dermatology Online Journal 2012). Strength, vehicle and duration are per prescriber. Monitor for local irritation and, with repeated mucosal or large-area use, thyroid function in neonates and patients with thyroid disease; in vitro cytotoxicity argues for stopping PVP-I once granulation tissue appears in wounds. Not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin using the applicator provided or a cotton swab. Let it dry before covering. Use an accurate measuring device if your label gives a volume. Keep it away from the eyes and avoid open flame if the solution contains alcohol. Wash your hands afterward.
Topical solutions are aqueous or alcohol based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Keep the bottle tightly closed at room temperature, away from heat and flame, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)